Skip to main content
Premium Trial:

Request an Annual Quote

Christopher Southan, Mark Allen, Peter Hecht, Betsy Humphreys

Premium

Christopher Southan will join the University of Nottingham as visiting professor of proteomics in the department of biosciences. Southan is currently bioinformatics group leader in the molecular pharmacology department of AstraZeneca R&D in Möndal, Sweden, and has also held bioinformatics positions at Oxford Glycosciences (now Oxford Genome Sciences) and Gemini Genomics.


Tripos has promoted Mark Allen to senior vice president and managing director of Tripos Discovery Research, its UK-based chemistry research facility. Allen will replace Peter Hecht, who is leaving the company to become CEO of Oridis Biomed. Hecht will continue to work with Tripos as a scientific advisor, the company said. Allen joined Tripos in 1998 as director of research and analytics. Previously, Allen was head of drug discovery support for Novartis Pharma UK.


Betsy Humphreys has been appointed deputy director of the National Library of Medicine, the parent institute for the National Center for Biotechnology Information at the National Institutes of Health. Humphreys joined the NLM in 1973 and most recently served as associate director for library operations.

Filed under

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.